Cargando…

OR34-02 Fasting Pancreatic Polypeptide Predicts Incident Microvascular And Macrovascular Complications Of Type 2 Diabetes

Disclosure: A.H. Sam: None. A.J. Buckley: None. B.Y. Lam: None. P.R. Bech: None. K. Meeran: None. M.T. Barakat: None. S.R. Bloom: None. G.S. Yeo: None. N.G. Lessan: None. K.G. Murphy: None. Background: Pancreatic polypeptide (PP) is elevated in people with Type 2 Diabetes (T2D) or with increased vis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sam, Amir H, Buckley, Adam J, Lam, Brian Y, Bech, Paul R, Meeran, Karim, Barakat, Maha T, Bloom, Stephen R, Yeo, Giles S, Lessan, Nader G, Murphy, Kevin G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555404/ http://dx.doi.org/10.1210/jendso/bvad114.1041

Ejemplares similares

THU337 Fructosamine As A Predictor Of Diabetic Microvascular Disease In A Population With High Prevalence Of Red Cell Disorders
por: John Buckley, Adam, et al.
Publicado: (2023)

OR12-02 NRF2 Is Essential For Expanding Pancreatic Beta-Cell Mass During Pregnancy
por: Baumel-Alterzon, Sharon, et al.
Publicado: (2023)

SAT037 Glucagon-like Peptide-1 Receptor Knockout Mice Do Not Compensate For The Lack Of Incretin Action By Increasing Glucose-dependent Insulinotropic Polypeptide Secretion
por: Douglas Galsgaard, Katrine, et al.
Publicado: (2023)

OR18-02 Mammary Insulin Sensitivity Increases At The Onset Of Lactation And Promotes Metabolic Pathways Supporting Breast Milk Synthesis
por: Meng, Xin, et al.
Publicado: (2023)

OR34-05 Second Phase Insulin Secretion Varies By Time Of Day And Body Mass Index
por: Naaman, Sandra, et al.
Publicado: (2023)

OR34-06 Gliclazide Restores Appropriate Glucagon Suppression During OGTT In MODY3 & MODY1 Patients: Results Of The “Glucagon In MODY” Study
por: Spiliotis, Ioannis Ilias, et al.
Publicado: (2023)

OR34-01 Incidence Of Diabetes Following COVID-19 Vaccination And SARS-CoV-2 Infection: A Population-Based Cohort Study
por: Lui, David, et al.
Publicado: (2023)

OR34-04 Defective FGFR1 Signaling Disrupts Glucose Regulation In Humans: Evidence From Patients With Isolated Hypogonadotropic Hypogonadism Harboring FGFR1 Mutations
por: Stamou, Maria, et al.
Publicado: (2023)

OR34-03 Defining Clinical Characteristics Of Patients With Severe Hypoglycemia After Roux-en-Y Gastric Bypass: How Do They Differ From Asymptomatic Patients?
por: Grover, Ashna, et al.
Publicado: (2023)

OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
por: Bellin, Melena, et al.
Publicado: (2022)

PSUN303 Nationwide Geospatial Analysis of Hospitalization in Diabetes Mellitus Complications
por: Lee, Claire, et al.
Publicado: (2022)

OR14-02 Circadian Regulation of Chromatin State Mediates Pancreatic Islet Incretin Response
por: Weidemann, Benjamin John, et al.
Publicado: (2020)

PSUN197 Rate of admission to the Intensive Care Unit in patients with Diabetic Ketoacidosis and its associated risk factors, a single centre experience.
por: Alotaibi, Raghad, et al.
Publicado: (2022)

SAT159 A Unique Case Of IGF-2 Induced Hypoglycemia As First Manifestation Of Hepatocellular Carcinoma
por: Ali, Israa, et al.
Publicado: (2023)

OR26-02 The Effect on Ketogenesis of Withholding Early Parenteral Nutrition in Critically Ill Children, as a Potential Mediator of the Improved Acute Outcome
por: De Bruyn, Astrid, et al.
Publicado: (2020)

OR14-6 The Role of the Angiopoietin-Tie2 Pathway in Microvascular Complications of Diabetes Mellitus
por: Brigell, Mitchell, et al.
Publicado: (2019)

Reconsidering the Basal Proportion of Insulin Dose: Glycemic and Microvascular Outcomes in Type 1 Diabetes Mellitus
por: Pozos-Varela, Francisco Javier, et al.
Publicado: (2021)

Ramadan Fasting: A Study of Changes in Glucose Profiles Among Patients With Diabetes Using Continuous Glucose Monitoring
por: Lessan, Nader, et al.
Publicado: (2012)

OR08-02 Do OGTT-based Insulin Secretory Response Measures Approximate 1(st) Phase Insulin Response in Pregnant Women?
por: Powe, Camille Elise, et al.
Publicado: (2020)

ODP245 Syndrome of Diabetic Ketoalkalosis due to Severe Hypercortisolemia: A Case Series
por: Uwaifo, Gabriel, et al.
Publicado: (2022)

THU293 Enhancement Of Best Practices In Diabetic Ketoacidosis Management Using Standardized Order-sets vs Individual Practitioner Orders
por: Yim, Carly, et al.
Publicado: (2023)

SAT142 Utilization Of Continuous Glucose Monitoring In Diagnosis And Management Of Insulinoma
por: Phan, Van, et al.
Publicado: (2023)

SAT070 The G Protein Coupled Receptor GPR31 Promotes Islet Inflammation And Diabetes
por: Checkcinco, Christian, et al.
Publicado: (2023)

PSUN272 Opportunity for Inpatient Use of Continuous Glucose Monitoring: A Case Report of Acute Pancreatitis Secondary to Hypertriglyceridemia
por: Romo, Karina G, et al.
Publicado: (2022)

THU299 Safety Of Immune Checkpoint Inhibitor Cancer Therapy In Patients With Pre-existing Type 1 Diabetes Mellitus: A Multi-Center Cohort Study
por: Hilder, Robin, et al.
Publicado: (2023)

LBSUN215 Evaluation Of Glycemic Control By Continuous Glucose Monitoring Among Hospitalized Older Adults With Type-2 Diabetes And Frailty
por: Idrees, Thaer, et al.
Publicado: (2022)

THU250 Therapeutic Inertia In Primary Care With Poor Information Transfer To Specialist Care - A Rural Irish Experience
por: Coughlan, Conor T, et al.
Publicado: (2023)

SAT075 Beta Cells Adapt To Insulin Resistance Via Posttranslational Modification Of The Translation Factor eIF5A
por: Anderson, Cara, et al.
Publicado: (2023)

SAT071 Inhibition Of 12 Lipoxygenase In A Humanized Mouse Model Of Type 1 Diabetes Delays Progression Of Hyperglycemia
por: Nargis, Titli, et al.
Publicado: (2023)

SAT066 Leukotriene B4 Receptor 2 Mediates Macrophage Migration To Injured β Cells
por: Ermis, Ebru, et al.
Publicado: (2023)

THU261 Etiologic Factors, Contributors, And Associations For Exocrine Pancreatic Insufficiency
por: Romo, Karina G, et al.
Publicado: (2023)

SAT068 The Golgi Transmembrane Protein GOLM1 Maintains PD-L1 Protein Levels In Islet Beta Cells In Response To Type 1 Diabetic Inflammation
por: huang, fei, et al.
Publicado: (2023)

SAT-182 Parathyroid CD34+ Cells Induce Angiogenesis Of Both Donor And Host As A Mechanism For Chimeric Vessel Formation
por: Kelly, Yvonne, et al.
Publicado: (2019)

SAT144 Hospital Hypoglycemia: An Analysis Of Risk Factors And Patients Outcomes
por: Pichardo-Lowden, Ariana R, et al.
Publicado: (2023)

FRI606 Changes In The Pedal Microcirculation Of Diabetic Patients With Poor Glycemic Control Detected Using Non Invasive Optical Imaging
por: Kendra Bolakale-Rufai, Ikeoluwapo, et al.
Publicado: (2023)

FRI613 Sex Differences In Human Islet Transcriptional Responses To Inflammation
por: Webster, Kierstin L, et al.
Publicado: (2023)

OR12-01 Blocking The Maladaptive Integrated Stress Response Increases Immunosuppressive PD-L1 In Pancreatic β-Cells
por: Muralidharan, Charanya, et al.
Publicado: (2023)

SAT041 (18)F-FDG PET/CT Mapping Of Functional Microbial Niches To Understand Host Glucose Regulation After BCG Vaccinations
por: Dias, Hans, et al.
Publicado: (2023)

FRI615 The 1-Hour OGTT Plasma Glucose As A Biomarker Of β-cell Function
por: Thomas Legvold, Brian, et al.
Publicado: (2023)

Comparison Between Linagliptin and Canagliflozin Effect on Inflammatory Markers, CD34+ Cell Gene Expression and Urine Exosomes in Type 2 Diabetes Subjects
por: Nandula, Seshagiri R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ad2c9qsni1s85kc6autmb29udf